0000878088-12-000009.txt : 20120109
0000878088-12-000009.hdr.sgml : 20120109
20120109171105
ACCESSION NUMBER: 0000878088-12-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120105
FILED AS OF DATE: 20120109
DATE AS OF CHANGE: 20120109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC.
CENTRAL INDEX KEY: 0000878088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223122182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TICE BOULEVARD
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
BUSINESS PHONE: 201-802-4000
MAIL ADDRESS:
STREET 1: 300 TICE BOULEVARD
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC
DATE OF NAME CHANGE: 19940526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZENNER PATRICK J
CENTRAL INDEX KEY: 0001139036
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10827
FILM NUMBER: 12518132
MAIL ADDRESS:
STREET 1: C/O DENDRITE INTERNATIONAL INC.
STREET 2: 1405/1425 ROUTE 206 SOUTH
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2012-01-05
0
0000878088
PAR PHARMACEUTICAL COMPANIES, INC.
PRX
0001139036
ZENNER PATRICK J
C/O PAR PHARMACEUTICAL COMPANIES INC.
300 TICE BLVD
WOODCLIFF LAKE
NJ
07677
1
0
0
0
Restricted Stock Units
2012-01-05
4
A
0
3816
0
A
2013-01-05
Common Stock
3816
10398
D
Pursuant to the Amended and Restated 1997 Directors' Stock and Deferred Fee Plan, the Reporting Person was granted a Restricted Stock Unit Award of the number of shares of the Issuer's common stock having an aggregate Fair Market Value equal to $125,000 on the date of grant. The Fair Market Value of each Restricted Stock Unit is equal to the closing price of the Issuer's common stock as reported by The New York Stock Exchange, Inc. on the date of grant, which was $32.76. The Restricted Stock Units vest one year from the anniversary of the date of grant. Each stock unit is the economic equivalent of one share of common stock, but the shares of common stock are distributed only upon termination of the Reporting Person's services as a director of the Issuer.
LIMITED POWER OF ATTORNEY: KNOW ALL MEN BY THESE PRESENTS, that the undersigned does hereby constitute and appoint MARIAN E. GUSTAFSON with full power to act, as his/her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him/her and in his/her name, place and stead, in any and all capacities, and to do any and all acts and things in his/her name and on his/her behalf, to execute any and all documents and instruments, which said attorney-in-fact may deem necessary or advisable to enable him/her to comply with the reporting requirements pursuant to Section 16 of the Securities Exchange Act of 1934, as amended, including but not limited to Form 4-Statement of Changes in Beneficial Ownership and Form 5-Annual Statement of Changes in Beneficial Ownership, relating to his/her ownership in Par Pharmaceutical Companies, Inc. (the "Company") for the period October 1, 2011 through and including September 30, 2012; and to file the same, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that the said attorney-in-fact and agent may lawfully do or cause to be done by virtue thereof. /s/ Patrick J. Zenner Dated: Sept. 9, 2011
/s/ Marian E. Gustafson for Patrick J. Zenner
2012-01-09